Abiopharma

(99% Neutral) EXODUS MOVEMENT, INC. (EXOD) Announces Regulatory Update

(30% Negative) GENCO SHIPPING & TRADING LTD (GNK) Reports Q2 2026 Financial Results

(30% Negative) EZCORP INC (EZPW) Reports Q2 2026 Financial Results

📋 Atlas Venture Fund XI, LP (Shareholder) plans to sell 44K shares of Dyne Therapeutics, Inc. (at $17.47 each, total $762K) Filed: May 06, 2026 | ID: 031384

Drafts William Arnold 🔴 sold 12.9K shares (1 derivative) of M-tron Industries, Inc. (MPTI) at $66.78 Transaction Date: May 04, 2026 | Filing ID: 015231

Director Pope Daniel M 🟡 adjusted position in 762 shares (2 derivative) of TYLER TECHNOLOGIES INC (TYL) Transaction Date: May 05, 2026 | Filing ID: 000018

📋 Atlas Venture Opportunity Fund II, LP (Shareholder) plans to sell 22K shares of Dyne Therapeutics, Inc. (at $17.47 each, total $383K) Filed: May 06, 2026 | ID: 031383

Director Forrester Michael A 🟢 acquired 1.7K shares of AFLAC INC (AFL) Transaction Date: May 04, 2026 | Filing ID: 000066

📋 Atlas Venture Associates XI, LP (Shareholder) plans to sell 428 shares of Dyne Therapeutics, Inc. (at $17.47 each, total $7K) Filed: May 06, 2026 | ID: 031382

(100% Positive) WATTS WATER TECHNOLOGIES INC (WTS) Reports Q2 2026 Financial Results

📋 Rummler Wendy A (Officer) plans to sell 2K shares of CREDIT ACCEPTANCE CORP (at $551.00 each, total $1.1M) Filed: May 06, 2026 | ID: 003357

📋 Atlas Venture Opportunity Fund I, LP (Shareholder) plans to sell 17K shares of Dyne Therapeutics, Inc. (at $17.47 each, total $301K) Filed: May 06, 2026 | ID: 031380

(10% Negative) CF INDUSTRIES HOLDINGS, INC. (CF) Reports Q2 2026 Financial Results

EZCORP Reports Second Quarter Fiscal 2026 Results

U.S. Global Investors Announces Q3 Fiscal Year 2026 Webcast